Improving tumour budding evaluation in colon cancer by extending the assessment area in colectomy specimens
Histopathology Aug 12, 2019
Martinez-Ciarpaglini C, Fernandez-Sellers C, Tarazona N, et al. - In an exploratory series of 172 cases of colon cancer in all stages, researchers focused on the contributions of various factors to enhancing tumour budding risk stratification: increasing the number of fields counted, using cytokeratin immunostaining, and recording proliferation, the apoptotic index and the emperipoletic index in tumour buds. They used a second cohort of 158 stage I–II patients to analyze the survival likelihood. In colon cancer patients, a significantly improved budding grade risk stratification was achieved by counting in 10 fields. For challenging cases with an inflammatory infiltrate and/or striking fibrosis, cytokeratin immunostaining could be saved as a complementary technique.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries